Oxidant stress and platelet activation in hypercholesterolemia

Antioxidants & Redox Signaling
Patrizia FerroniGiovanni Davì

Abstract

Hypercholesterolemia is the dominant risk factor associated with atherothrombotic disorders in the western world. Consequently, much attention has been devoted to defining its role in the pathogenesis of atherosclerosis. It is currently recognized that hypercholesterolemia induces phenotypic changes in the microcirculation that are consistent with oxidative and nitrosative stresses. Superoxide is generated via several cellular systems and, once formed, participates in a number of reactions, yielding various free radicals, such as hydrogen peroxide, peroxynitrite, or oxidized low-density lipoproteins. Once oxidant stress is invoked, characteristic pathophysiologic features ensue, such as platelet activation and lipid peroxidation, which are both involved in the initiation and progression of the atherosclerotic lesions. Thus, therapeutic strategies that act to maintain the normal balance in the oxidant status of the vascular bed may prove effective in reducing the deleterious consequences of hypercholesterolemia.

References

May 1, 1977·The Journal of Clinical Investigation·R I HandinG J Boxer
Oct 1, 1992·Free Radical Biology & Medicine·H EsterbauerG Jürgens
Jun 1, 1992·Cell Biochemistry and Function·M MarescaG Leoncini
Aug 1, 1989·British Journal of Pharmacology·D SalveminiJ R Vane
Jan 1, 1986·Progress in Lipid Research·W E Lands, R J Kulmacz
Oct 21, 1986·Biochemistry·D A Lawrence, D J Loskutoff
Mar 1, 1987·The Biochemical Journal·H E AndrewsK R Bruckdorfer
Aug 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·F CatellaG A FitzGerald
Jan 15, 1985·Thrombosis Research·E Gray, T W Barrowcliffe
Sep 17, 1982·Biochimica Et Biophysica Acta·A Finazzi-AgròD Del Principe
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·M A MoroS Moncada
Aug 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·A WeidtmannW Siess
Feb 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·A NotarbartoloC Patrono
Sep 17, 1994·Lancet·J L Witztum
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·C R WhiteB A Freeman
Jul 30, 1993·Biochemical and Biophysical Research Communications·T MalinskiS Moncada
Jun 1, 1993·The Journal of Clinical Investigation·Y OharaD G Harrison
Oct 1, 1995·British Journal of Pharmacology·M A MoroS Moncada
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·C R WhiteB A Freeman
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·L M LandinoL J Marnett
Jan 17, 1997·The Journal of Biological Chemistry·C LeeuwenburghJ W Heinecke
Jan 1, 1997·Free Radical Biology & Medicine·T H MondoroJ G Vostal
Jul 15, 1997·The Journal of Clinical Investigation·J E FreedmanA D Michelson
Jun 1, 1997·Cardiovascular Research·G AmbrosioP Golino

❮ Previous
Next ❯

Citations

Mar 28, 2006·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Nese Karaaslan BiyikliTurgay Ispir
Jul 10, 2004·Antioxidants & Redox Signaling·Agnes Görlach
Aug 24, 2005·Antioxidants & Redox Signaling·Agnes Görlach
Sep 21, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Ruibin FuJian Qiu
Jul 25, 2007·Clinical and Experimental Pharmacology & Physiology·Rao M UppuPhilip J Kadowitz
Jul 28, 2012·Therapeutic Delivery·Jingyan HanVladimir R Muzykantov
Mar 7, 2014·Antioxidants & Redox Signaling·Donatella PietraforteElisabetta Straface
Jun 1, 2012·TheScientificWorldJournal·Pallavi Mishra, Luna Samanta
Dec 2, 2008·Microvascular Research·Adel Boueiz, Paul M Hassoun
May 8, 2016·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Michel LagardeEvelyne Véricel
Apr 4, 2006·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·P FerroniG Davì
Jan 19, 2008·Journal of Vascular Surgery·Stefan MustafaSabine Eichinger
Aug 16, 2016·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Michel LagardeEvelyne Véricel
Jan 13, 2018·Journal of Cellular Physiology·Hamid MollazadehAmirhossein Sahebkar
Dec 8, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Pasquale PignatelliFrancesco Violi
Apr 17, 2019·Journal of Clinical Pharmacy and Therapeutics·Juan GuoJuan Feng
Aug 29, 2019·Frontiers in Endocrinology·Marina Di DomenicoMariarosaria Boccellino
Jul 15, 2020·International Journal of Molecular Sciences·Elena MasselliGiuliana Gobbi
Aug 11, 2017·PloS One·Peter KraftStefanie Schreiber

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.